October 20, 2026 at 11:02 AM UTC
8-K - Odyssey Therapeutics, Inc. (0001882782) (Filer)
Filed: 2026-10-20 AccNo: 0001193125-26-425684 Size: 21 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Official source: U.S. Securities and Exchange Commission
Official source published: October 20, 2026 at 11:00 AM UTC
Open official source